CuraVac CuraVac is a biopharmaceutical company focused on the development of immunotherapies for treating autoimmune and inflammatory diseases including myasthenia gravis (MG), multiple sclerosis (MS), etc. | ||
Founding Date | Founding Date 2002 | Founding Date 2018 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Wilmington, US HQ Rixensart, BE | Locations Milano, IT HQ |
Employees | Employees 717% increase | Employees 428 |
Neopharmed Gentili is a pharmaceutical company.
View company